Phoenixus AG is the parent company of Vyera Pharmaceuticals, per their website. This is the very reason the restricted shares -- ie float -- is incredibly small.
<<Averill L. Powers, Chief Executive Officer of Phoenixus AG, Vyera's parent company, noted: "Vyera's collaboration with CytoDyn demonstrates our commitment to address the needs of significant patient populations across our group companies generally and, in particular, a new level of our commitment to supporting patients living with HIV.">>